远程心脏康复对应用蒽环类药物化疗的乳腺 癌患者的影响
The Impact of Remote Cardiac Rehabilitation on Breast Cancer Patients Undergoing Anthracycline-Based Chemotherapy
DOI: 10.12677/acm.2026.1662313, PDF,    科研立项经费支持
作者: 高 杰, 袁娴雅, 郭桂月, 左洪铭, 范振崴*:北华大学护理学院,吉林 吉林
关键词: 乳腺癌蒽环类药物心脏毒性心脏康复Breast Cancer Anthracyclines Cardiotoxicity Cardiac Rehabilitation
摘要: 目的:探讨远程心脏康复对蒽环类药物化疗的乳腺癌患者心肺功能及生活质量的影响。方法:将30例接受蒽环类药物化疗的乳腺癌患者随机分为实验组(n = 15)和对照组(n = 15)。实验组接受为期6个月的远程心脏康复,对照组接受常规护理与健康教育。干预前后分别测量两组患者的静息心率、最大摄氧量(VO₂ peak),并采用生活质量评估量表(36-Item Short Form Health Survey, SF-36)评估生活质量。采用SPSS 27.0进行分析,采用重复测量方差分析分析结果。结果:干预后,实验组静息心率显著减慢(P < 0.001),最大摄氧量显著提升(P < 0.001);生命质量核心量表30评分显著提升。对照组上述指标无明显变化。结论:远程心脏康复可有效改善蒽环类药物化疗乳腺癌患者的心肺功能及生活质量,为临床开展肿瘤患者远程心脏康复提供了有效参考。
Abstract: Objective: To explore the impact of remote cardiac rehabilitation on the cardiopulmonary function and quality of life of breast cancer patients undergoing anthracycline chemotherapy. Methods: Thirty breast cancer patients receiving anthracycline chemotherapy were randomly divided into an experimental group (n = 15) and a control group (n = 15). The experimental group received a 6-month remote cardiac rehabilitation program, while the control group received routine care and health education. Resting heart rate and peak oxygen uptake (VO2 peak) were measured in both groups before and after the intervention, and quality of life was assessed using the 36-Item Short Form Health Survey (SF-36). Data were analyzed using SPSS 27.0, and repeated measures ANOVA were used to analyze the results. Results: After the intervention, the experimental group showed a significant decrease in resting heart rate (P < 0.001) and a significant increase in peak oxygen uptake (P < 0.001), with a significant improvement in the SF-36 score. There were no significant changes in the control group. Conclusion: Remote cardiac rehabilitation can effectively improve the cardiopulmonary function and quality of life of breast cancer patients undergoing anthracycline chemotherapy, providing an effective reference for the clinical implementation of remote cardiac rehabilitation for cancer patients.
文章引用:高杰, 袁娴雅, 郭桂月, 左洪铭, 范振崴. 远程心脏康复对应用蒽环类药物化疗的乳腺 癌患者的影响[J]. 临床医学进展, 2026, 16(6): 1076-1081. https://doi.org/10.12677/acm.2026.1662313

参考文献

[1] Hangcheng, X. and Binghe, X. (2025) Epidemiology, Early Detection, and Management of Breast Cancer in China: A Comprehensive Review. Chinese Journal of Cancer Research, 37, 882-899. [Google Scholar] [CrossRef
[2] Loibl, S., Poortmans, P., Morrow, M., Denkert, C. and Curigliano, G. (2021) Breast Cancer. The Lancet, 397, 1750-1769. [Google Scholar] [CrossRef] [PubMed]
[3] Swain, S.M., Whaley, F.S. and Ewer, M.S. (2003) Congestive Heart Failure in Patients Treated with Doxorubicin: A Retrospective Analysis of Three Trials. Cancer, 97, 2869-2879. [Google Scholar] [CrossRef] [PubMed]
[4] Bozkurt, B., Fonarow, G.C., Goldberg, L.R., Guglin, M., Josephson, R.A., Forman, D.E., et al. (2021) Cardiac Rehabilitation for Patients with Heart Failure. Journal of the American College of Cardiology, 77, 1454-1469. [Google Scholar] [CrossRef] [PubMed]
[5] Gradishar, W.J., Moran, M.S., Abraham, J., Abramson, V., Aft, R., Agnese, D., et al. (2024) Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 22, 331-357. [Google Scholar] [CrossRef] [PubMed]
[6] 中国抗癌协会乳腺癌专业委员会, 中华医学会肿瘤学分会乳腺肿瘤学组. 中国抗癌协会乳腺癌诊治指南与规范(2024年版) [J]. 中国癌症杂志, 2023, 33(12): 1092-1187.
[7] Gilchrist, S.C., Barac, A., Ades, P.A., Alfano, C.M., Franklin, B.A., Jones, L.W., et al. (2019) Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement from the American Heart Association. Circulation, 139, e997-e1012. [Google Scholar] [CrossRef] [PubMed]
[8] Ling, G., Ge, F., Li, W., Wei, Y., Guo, S., Zhang, Y., et al. (2025) Anthracycline-Induced Cardiotoxicity: Emerging Mechanisms and Therapies. Medicine Plus, 2, Article ID: 100074. [Google Scholar] [CrossRef
[9] Dozic, S., Howden, E.J., Bell, J.R., Mellor, K.M., Delbridge, L.M.D. and Weeks, K.L. (2023) Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy. Cells, 12, Article 1312. [Google Scholar] [CrossRef] [PubMed]
[10] Adams, S.C., Rivera-Theurel, F., Scott, J.M., Nadler, M.B., Foulkes, S., Leong, D., et al. (2025) Cardio-Oncology Rehabilitation and Exercise: Evidence, Priorities, and Research Standards from the ICOS-CORE Working Group. European Heart Journal, 46, 2847-2865. [Google Scholar] [CrossRef] [PubMed]